Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Adrienne, Baughman"'
Autor:
Caitlin Turbyfill, Katherine Adams, Mark W. Tenforde, Nancy L. Murray, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal, Shekhar Ghamande, David J. Douin, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Nathan I. Shapiro, Kevin W. Gibbs, D. Clark Files, David N. Hager, Arber Shehu, Matthew E. Prekker, Anne E. Frosch, Matthew C. Exline, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Adam S. Lauring, Akram Khan, Laurence W. Busse, Caitlin C. ten Lohuis, Abhijit Duggal, Jennifer G. Wilson, Alexandra June Gordon, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Jennie H. Kwon, Natasha Halasa, James D. Chappell, Carlos G. Grijalva, Todd W. Rice, William B. Stubblefield, Adrienne Baughman, Jillian P. Rhoads, Christopher J. Lindsell, Kimberly W. Hart, Meredith McMorrow, Diya Surie, Wesley H. Self, Manish M. Patel
Publikováno v:
Vaccine, vol 40, iss 48
BackgroundTest-negative design (TND) studies have produced validated estimates of vaccine effectiveness (VE) for influenza vaccine studies. However, syndrome-negative controls have been proposed for differentiating bias and true estimates in VE evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f3d4d9eebaaa287a091629da3368667
https://doi.org/10.1016/j.vaccine.2022.10.034
https://doi.org/10.1016/j.vaccine.2022.10.034
Autor:
Diya, Surie, Levi, Bonnell, Katherine, Adams, Manjusha, Gaglani, Adit A, Ginde, David J, Douin, H Keipp, Talbot, Jonathan D, Casey, Nicholas M, Mohr, Anne, Zepeski, Tresa, McNeal, Shekhar, Ghamande, Kevin W, Gibbs, D Clark, Files, David N, Hager, Arber, Shehu, Anne P, Frosch, Heidi L, Erickson, Michelle N, Gong, Amira, Mohamed, Nicholas J, Johnson, Vasisht, Srinivasan, Jay S, Steingrub, Ithan D, Peltan, Samuel M, Brown, Emily T, Martin, Akram, Khan, William S, Bender, Abhijit, Duggal, Jennifer G, Wilson, Nida, Qadir, Steven Y, Chang, Christopher, Mallow, Carolina, Rivas, Jennie H, Kwon, Matthew C, Exline, Adam S, Lauring, Nathan I, Shapiro, Natasha, Halasa, James D, Chappell, Carlos G, Grijalva, Todd W, Rice, William B, Stubblefield, Adrienne, Baughman, Kelsey N, Womack, Kimberly W, Hart, Sydney A, Swan, Yuwei, Zhu, Jennifer, DeCuir, Mark W, Tenforde, Manish M, Patel, Meredith L, McMorrow, Wesley H, Self, Carleigh, Samuels
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:1327-1334
The SARS-CoV-2 Omicron variant (B.1.1.529 or BA.1) became predominant in the United States by late December 2021 (1). BA.1 has since been replaced by emerging lineages BA.2 (including BA.2.12.1) in March 2022, followed by BA.4 and BA.5, which have ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198a0fb85e6ad0bdec844161784e9cab
https://doi.org/10.15585/mmwr.mm7142a3
https://doi.org/10.15585/mmwr.mm7142a3
Autor:
Meagan, Stephenson, Samantha M, Olson, Wesley H, Self, Adit A, Ginde, Nicholas M, Mohr, Manjusha, Gaglani, Nathan I, Shapiro, Kevin W, Gibbs, David N, Hager, Matthew E, Prekker, Michelle N, Gong, Jay S, Steingrub, Ithan D, Peltan, Emily T, Martin, Raju, Reddy, Laurence W, Busse, Abhijit, Duggal, Jennifer G, Wilson, Nida, Qadir, Christopher, Mallow, Jennie H, Kwon, Matthew C, Exline, James D, Chappell, Adam S, Lauring, Adrienne, Baughman, Christopher J, Lindsell, Kimberly W, Hart, Nathaniel M, Lewis, Manish M, Patel, Mark W, Tenforde
Publikováno v:
Influenza and Other Respiratory Viruses. 16:1101-1111
During the COVID-19 pandemic, self-reported COVID-19 vaccination might facilitate rapid evaluations of vaccine effectiveness (VE) when source documentation (e.g., immunization information systems [IIS]) is not readily available. We evaluated the conc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69db2bb474b04e0b1783a450b9e935cf
https://doi.org/10.1111/irv.13023
https://doi.org/10.1111/irv.13023
Autor:
Nathaniel M, Lewis, Wesley H, Self, Manjusha, Gaglani, Adit A, Ginde, David J, Douin, H, Keipp Talbot, Jonathan D, Casey, Nicholas M, Mohr, Anne, Zepeski, Shekhar A, Ghamande, Tresa A, McNeal, Nathan I, Shapiro, Kevin W, Gibbs, D Clark, Files, David N, Hager, Arber, Shehu, Matthew E, Prekker, Heidi L, Erickson, Michelle N, Gong, Amira, Mohamed, Nicholas J, Johnson, Vasisht, Srinivasan, Jay S, Steingrub, Ithan D, Peltan, Samuel M, Brown, Emily T, Martin, Arnold S, Monto, Akram, Khan, Laurence W, Busse, Caitlin C Ten, Lohuis, Abhijit, Duggal, Jennifer G, Wilson, Alexandra June, Gordon, Nida, Qadir, Steven Y, Chang, Christopher, Mallow, Carolina, Rivas, Hilary M, Babcock, Jennie H, Kwon, Matthew C, Exline, Adam S, Lauring, Natasha, Halasa, James D, Chappell, Carlos G, Grijalva, Todd W, Rice, Jillian P, Rhoads, Ian D, Jones, William B, Stubblefield, Adrienne, Baughman, Kelsey N, Womack, Christopher J, Lindsell, Kimberly W, Hart, Yuwei, Zhu, Katherine, Adams, Manish M, Patel, Mark W, Tenforde
Publikováno v:
Clinical Infectious Diseases. 75:S159-S166
Background . Adults in the United States (US) began receiving the adenovirus vector coronavirus disease 2019 (COVID-19) vaccine, Ad26.COV2.S (Johnson & Johnson [Janssen]), in February 2021. We evaluated Ad26.COV2.S vaccine effectiveness (VE) against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4efe6f52aace78e5793a53d83a0ad8
https://doi.org/10.1093/cid/ciac439
https://doi.org/10.1093/cid/ciac439
Autor:
Diya Surie, Levi Bonnell, Jennifer DeCuir, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande, Jay S. Steingrub, Nathan Shapiro, Laurence W. Busse, Matthew E. Prekker, Ithan D. Peltan, Samuel M. Brown, David Hager, Harith Ali, Michelle Ng Gong, amira mohamed, Akram Khan, Jennifer Wilson, Nida Qadir, Steven Chang, Adit A. Ginde, David Huynh, Nicholas Mohr, Christopher Mallow, Emily T. Martin, Adam S. Lauring Lauring, Nicholas J. Johnson, Jonathan D. Casey, Kevin W. Gibbs, Jennie H. Kwon, Adrienne Baughman, James D. Chappell, Kimberly W. Hart, Carlos G. Grijalva, Jillian Rhoads, Sydney A. Swan, H. Keipp Talbot, Kelsey N. Womack, Yuwei Zhu, Mark W. Tenforde, Katherine Adams, Wesley H. Self, Meredith L. McMorrow
Publikováno v:
Vaccine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12f424a47c9fe9246c48d3d6f51a3cb6
https://doi.org/10.1016/j.vaccine.2023.05.028
https://doi.org/10.1016/j.vaccine.2023.05.028
Autor:
Nannan Jiang, Li Wang, Masato Hatta, Chenchen Feng, Michael Currier, Xudong Lin, Jaber Hossain, Dan Cui, Brian R. Mann, Nicholas A. Kovacs, Wei Wang, Ginger Atteberry, Malania Wilson, Reina Chau, Kristine A. Lacek, Clinton R. Paden, Norman Hassell, Benjamin Rambo-Martin, John R. Barnes, Rebecca J. Kondor, Wesley H. Self, Jillian P. Rhoads, Adrienne Baughman, James D. Chappell, Nathan I. Shapiro, Kevin W. Gibbs, David N. Hager, Adam S. Lauring, Diya Surie, Meredith L. McMorrow, Natalie J. Thornburg, David E. Wentworth, Bin Zhou
The early Omicron lineage variants evolved and gave rise to diverging lineages that fueled the COVID-19 pandemic in 2022. Bivalent mRNA vaccines, designed to broaden protection against circulating and future variants, were authorized by the U.S. Food
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3469686901282314c4345ea9eb99edd0
https://doi.org/10.1101/2023.01.08.523127
https://doi.org/10.1101/2023.01.08.523127
Autor:
Anne Zepeski, Catherine L. Hough, Wesley H. Self, Ian Jones, Amira Mohamed, Tresa McNeal, Samuel M. Brown, Shekhar Ghamande, Jennifer G. Wilson, Alexandra June Gordon, Eric A. Naioti, Manjusha Gaglani, Jay S. Steingrub, Steven Y. Chang, Natalie J. Thornburg, Yuwei Zhu, Adrienne Baughman, Mark W Tenforde, Matthew E. Prekker, Christopher J. Lindsell, William B. Stubblefield, Arnold S. Monto, Nida Qadir, James D. Chappell, Nicholas M. Mohr, Carolina Rivas, Sandra N. Lester, Abhijit Duggal, Ithan D. Peltan, Kevin W Gibbs, Jillian P. Rhoads, Jennifer R. Verani, Miwako Kobayashi, Hilary M. Babcock, Manish M. Patel, Arber Shehu, Emily T. Martin, Natasha B. Halasa, Laurence W. Busse, Megan M. Stump, Jennie H. Kwon, David J. Douin, Daniel J. Henning, Matthew C. Exline, Kelsey N Womack, Michelle N. Gong, Todd W. Rice, Samantha M. Olson, H. Keipp Talbot, Adam S. Lauring, Jonathan D Casey, Adit A. Ginde, Kimberly W. Hart, Heidi L Erickson, D. Clark Files, David N. Hager, Carlos G. Grijalva, Lisa Mills, Christopher Mallow, Akram Khan, Caitlin C Ten Lohuis
Publikováno v:
Morbidity and Mortality Weekly Report
Three COVID-19 vaccines are authorized or approved for use among adults in the United States (1,2). Two 2-dose mRNA vaccines, mRNA-1273 from Moderna and BNT162b2 from Pfizer-BioNTech, received Emergency Use Authorization (EUA) by the Food and Drug Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3695ec34b8521f85c10fe2b51a1b6080
https://doi.org/10.15585/mmwr.mm7038e1
https://doi.org/10.15585/mmwr.mm7038e1
Autor:
Katherine Adams, Jillian P. Rhoads, Diya Surie, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal, Shekhar Ghamande, David Huynh, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Nathan I. Shapiro, Kevin W. Gibbs, D. Clark Files, Madeline Hicks, David N. Hager, Harith Ali, Matthew E. Prekker, Anne E. Frosch, Matthew C. Exline, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Arnold S. Monto, Adam S. Lauring, Akram Khan, Catherine L. Hough, Laurence W. Busse, Caitlin C. ten Lohuis, Abhijit Duggal, Jennifer G. Wilson, Alexandra June Gordon, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Hilary M. Babcock, Jennie H. Kwon, James D. Chappell, Natasha Halasa, Carlos G. Grijalva, Todd W. Rice, William B. Stubblefield, Adrienne Baughman, Christopher J. Lindsell, Kimberly W. Hart, Sandra N. Lester, Natalie J. Thornburg, SoHee Park, Meredith L. McMorrow, Manish M. Patel, Mark W. Tenforde, Wesley H. Self
Publikováno v:
medRxiv
To compare the effectiveness of a primary covid-19 vaccine series plus booster doses with a primary series alone for the prevention of hospital admission with omicron related covid-19 in the United States.Multicenter observational case-control study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8e0aea8d33df92e3efc865bd23c2488
https://doi.org/10.1101/2022.06.09.22276228
https://doi.org/10.1101/2022.06.09.22276228
Autor:
Carlos G. Grijalva, Michelle N. Gong, Todd W. Rice, Matthew E. Prekker, Adrienne Baughman, Samuel K. Nwosu, Manish M. Patel, Jay S. Steingrub, Ithan D. Peltan, Nathan I. Shapiro, Matthew C. Exline, Leora R. Feldstein, Kevin W Gibbs, Christopher J. Lindsell, Natasha B. Halasa, William B Stubblefield, H. Keipp Talbot, Michael S. Aboodi, Heidi L Erickson, Akram Khan, Mark W Tenforde, D. Clark Files, Wesley H. Self, Jonathan D Casey, Adit A. Ginde, Samuel M. Brown
Publikováno v:
Clin Infect Dis
Background Influenza vaccine effectiveness (VE) against a spectrum of severe disease, including critical illness and death, remains poorly characterized. Methods We conducted a test-negative study in an intensive care unit (ICU) network at 10 US hosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::724fb13c73e6e84ac0265c2b2498feda
https://doi.org/10.1093/cid/ciab462
https://doi.org/10.1093/cid/ciab462
Autor:
Matthew E. Prekker, Nathan I. Shapiro, Michelle N. Gong, Todd W. Rice, Samuel M. Brown, Adrienne Baughman, Jill M. Ferdinands, Kevin W Gibbs, Ithan D. Peltan, Christopher J. Lindsell, Manish M. Patel, D. Clark Files, H. Keipp Talbot, Matthew C. Exline, Leora R. Feldstein, Carlos G. Grijalva, Margaret M Newhams, Jay S. Steingrub, Akram Khan, Wesley H. Self, Michael S. Aboodi, Adrienne G. Randolph, Adit A. Ginde, M. Elizabeth Halloran, Natasha B. Halasa
Publikováno v:
J Infect Dis
Background Test-negative design studies for evaluating influenza vaccine effectiveness (VE) enroll patients with acute respiratory infection. Enrollment typically occurs before influenza status is determined, resulting in over-enrollment of influenza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cbde3609d8b796faa6444813f39454a
https://doi.org/10.1093/infdis/jiab273
https://doi.org/10.1093/infdis/jiab273